249 related articles for article (PubMed ID: 19074516)
1. Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death.
Scirica BM; Cannon CP; Sabatine MS; Jarolim P; Sloane S; Rifai N; Braunwald E; Morrow DA;
Clin Chem; 2009 Feb; 55(2):265-73. PubMed ID: 19074516
[TBL] [Abstract][Full Text] [Related]
2. Biomarker of Collagen Turnover (C-Terminal Telopeptide) and Prognosis in Patients With Non- ST -Elevation Acute Coronary Syndromes.
Zelniker TA; Jarolim P; Scirica BM; Braunwald E; Park JG; Das S; Sabatine MS; Morrow DA
J Am Heart Assoc; 2019 May; 8(9):e011444. PubMed ID: 31020897
[TBL] [Abstract][Full Text] [Related]
3. Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study.
Scirica BM; Morrow DA; Cannon CP; Ray KK; Sabatine MS; Jarolim P; Shui A; McCabe CH; Braunwald E;
J Am Coll Cardiol; 2006 Jun; 47(11):2326-31. PubMed ID: 16750703
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death: just another brick in the wall?
Collinson PO
Clin Chem; 2009 Feb; 55(2):203-5. PubMed ID: 19095728
[No Abstract] [Full Text] [Related]
5. Interleukin-6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib-Thrombolysis in Myocardial Infarction 52) Trial.
Fanola CL; Morrow DA; Cannon CP; Jarolim P; Lukas MA; Bode C; Hochman JS; Goodrich EL; Braunwald E; O'Donoghue ML
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066436
[TBL] [Abstract][Full Text] [Related]
6. B-type natriuretic peptide and high sensitive C-reactive protein predict 2-year all cause mortality in chest pain patients: a prospective observational study from Salta, Argentina.
León de la Fuente R; Naesgaard PA; Nilsen ST; Woie L; Aarsland T; Gallo P; Grundt H; Staines H; Nilsen DW
BMC Cardiovasc Disord; 2011 Sep; 11():57. PubMed ID: 21958326
[TBL] [Abstract][Full Text] [Related]
7. B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: a prognostic study.
Brügger-Andersen T; Pönitz V; Staines H; Pritchard D; Grundt H; Nilsen DW
BMC Cardiovasc Disord; 2008 Nov; 8():34. PubMed ID: 19032759
[TBL] [Abstract][Full Text] [Related]
8. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
[TBL] [Abstract][Full Text] [Related]
9. Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome.
Mjelva ØR; Pönitz V; Brügger-Andersen T; Grundt H; Staines H; Nilsen DW
Eur J Prev Cardiol; 2016 Jul; 23(11):1130-40. PubMed ID: 26635361
[TBL] [Abstract][Full Text] [Related]
10. Increased perioperative b-type natriuretic peptide associates with heart failure hospitalization or heart failure death after coronary artery bypass graft surgery.
Fox AA; Nascimben L; Body SC; Collard CD; Mitani AA; Liu KY; Muehlschlegel JD; Shernan SK; Marcantonio ER
Anesthesiology; 2013 Aug; 119(2):284-94. PubMed ID: 23695172
[TBL] [Abstract][Full Text] [Related]
11. Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial.
Mani P; Puri R; Schwartz GG; Nissen SE; Shao M; Kastelein JJP; Menon V; Lincoff AM; Nicholls SJ
JAMA Cardiol; 2019 Apr; 4(4):314-320. PubMed ID: 30840024
[TBL] [Abstract][Full Text] [Related]
12. Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study.
Brozaitiene J; Mickuviene N; Podlipskyte A; Burkauskas J; Bunevicius R
BMC Cardiovasc Disord; 2016 Feb; 16():45. PubMed ID: 26892923
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of plasma brain natriuretic peptide and C-reactive protein in patients with acute coronary syndromes underwent percutaneous coronary intervention].
He B; Ding S; Pu J; Liu JP; Song W; Du YP; Shen JY; Jin SX; Sun Y; Shen L
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):349-52. PubMed ID: 16776932
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Value of Serum Levels of Heart-Type Fatty Acid Binding Protein and High Sensitivity C-Reactive Protein in Patients With Increased Levels of Amino-Terminal Pro-B Type Natriuretic Peptide.
Jeong JH; Seo YH; Ahn JY; Kim KH; Seo JY; Kim MJ; Lee HT; Park PW
Ann Lab Med; 2016 Sep; 36(5):420-6. PubMed ID: 27374706
[TBL] [Abstract][Full Text] [Related]
15. Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.
Latini R; Gullestad L; Masson S; Nymo SH; Ueland T; Cuccovillo I; Vårdal M; Bottazzi B; Mantovani A; Lucci D; Masuda N; Sudo Y; Wikstrand J; Tognoni G; Aukrust P; Tavazzi L;
Eur J Heart Fail; 2012 Sep; 14(9):992-9. PubMed ID: 22740508
[TBL] [Abstract][Full Text] [Related]
16. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
17. B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary-Thrombolysis In Myocardial Infarction 36) trial.
Morrow DA; Scirica BM; Sabatine MS; de Lemos JA; Murphy SA; Jarolim P; Theroux P; Bode C; Braunwald E
J Am Coll Cardiol; 2010 Mar; 55(12):1189-1196. PubMed ID: 20298924
[TBL] [Abstract][Full Text] [Related]
18. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
Suzuki S; Sugiyama S
Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
[TBL] [Abstract][Full Text] [Related]
19. High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial.
Kalogeropoulos AP; Tang WH; Hsu A; Felker GM; Hernandez AF; Troughton RW; Voors AA; Anker SD; Metra M; McMurray JJ; Massie BM; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Butler J
J Card Fail; 2014 May; 20(5):319-26. PubMed ID: 24530944
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease.
Morrow DA; de Lemos JA; Blazing MA; Sabatine MS; Murphy SA; Jarolim P; White HD; Fox KA; Califf RM; Braunwald E;
JAMA; 2005 Dec; 294(22):2866-71. PubMed ID: 16352794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
